HBIO - HARVARD BIOSCIENCE INC
4.87
-0.200 -4.107%
Share volume: 39,736
Last Updated: 03-27-2026
Measuring And Control Equipment/Lab Analytical Instruments:
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$5.07
-0.20
-0.04%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-07-2024 | 08-08-2024 | 11-08-2024 | 03-13-2025 | 05-12-2025 | 08-11-2025 | 11-06-2025 | 03-13-2026 | |
| Assets | |||||||||
| Total Assets | 133.161 M | 128.912 M | 131.239 M | 126.644 M | 79.801 M | 80.093 M | 77.992 M | 80.071 M | |
| Current Assets | 48.148 M | 46.430 M | 46.791 M | 45.117 M | 44.902 M | 44.969 M | 43.805 M | 48.225 M | |
| Inventories | 24.136 M | 25.130 M | 25.990 M | 23.245 M | 22.816 M | 22.255 M | 21.604 M | 20.805 M | |
| Other Current Assets | 4.448 M | 4.766 M | 3.401 M | 2.898 M | 3.061 M | 3.335 M | 3.275 M | 2.763 M | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 4.255 M | 4.048 M | 4.569 M | 4.108 M | 5.546 M | 7.442 M | 6.817 M | 8.614 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 4.492 M | 4.758 M | 5.221 M | 5.106 M | 5.009 M | 4.913 M | 4.990 M | 4.787 M | |
| Other Assets | 80.521 M | 77.724 M | 79.227 M | 76.421 M | 29.890 M | 30.211 M | 29.197 M | 27.059 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 133.161 M | 128.912 M | 131.239 M | 126.644 M | 79.801 M | 80.093 M | 77.992 M | 80.071 M | |
| Total liabilities | 64.349 M | 61.665 M | 65.917 M | 63.304 M | 64.966 M | 64.360 M | 63.924 M | 66.337 M | |
| Total current liabilities | 25.677 M | 22.621 M | 22.751 M | 54.958 M | 55.603 M | 55.202 M | 54.396 M | 21.960 M | |
| Accounts Payable | 6.044 M | 5.711 M | 5.283 M | 4.787 M | 4.808 M | 4.722 M | 5.176 M | 3.652 M | |
| Other liabilities | 6.010 M | 6.320 M | 8.207 M | 7.636 M | 8.646 M | 8.424 M | 8.795 M | 8.190 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 31.890 M | 31.960 M | 34.252 M | 0.000 | 0.000 | 0.000 | 0.000 | 35.870 M | |
| Other liabilities | 6.010 M | 6.320 M | 8.207 M | 7.636 M | 8.646 M | 8.424 M | 8.795 M | 8.190 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 68.812 M | 67.247 M | 65.322 M | 63.340 M | 14.835 M | 15.733 M | 14.068 M | 13.734 M | |
| Common stock | 233.885 M | 235.341 M | 236.409 M | 237.020 M | 237.546 M | 238.067 M | 238.368 M | 240.116 M | |
| Retained earnings | -150.299 M | -153.226 M | -158.028 M | -158.010 M | -208.350 M | -210.632 M | -211.863 M | -214.710 M |